Delivery Order SPE2DP20D0002-SPE2DP25F054E
Award Date 8/12/25
Potential Completion Date 8/26/25
Potential Value $661K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Parsippany, NJ 07054, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of Defense's Medical Supply Chain division awarded a $1.16M firm fixed-price delivery order to Teva Pharmaceuticals USA, Inc. for Adenovirus Type 4 vaccine, with an ultimate completion date of August 26, 2025. The contract, which carries no set-aside designation, will be performed at Teva's manufacturing facility in Parsippany, New Jersey. This delivery order represents a continuation of Teva's established role as a critical supplier of vaccines and pharmaceutical products to...
- Teva Pharmaceuticals USA, Inc. has been awarded a $1,526,969 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply adenovirus type 4 vaccine. This delivery order was issued under an existing contract vehicle and will support the immunization programs of the military. Teva will deliver the vaccine products to the agency's location in Parsippany, New Jersey by December 19, 2023. As a major pharmaceutical manufacturer, Teva has extensive experience...
- Teva Pharmaceuticals USA, Inc. received a $330,314 firm fixed-price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical for Adenovirus Type 4 vaccine, with performance scheduled in Parsippany, New Jersey and completion by August 26, 2025. This contract was awarded without set-aside designation on August 12, 2025, reflecting Teva's competitive positioning as a large business in unrestricted solicitations. The Adenovirus Type 4 vaccine is a critical immunization product...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a Firm Fixed Price Delivery Order contract to Teva Pharmaceuticals USA, Inc. for the delivery of Adenovirus Type 4 vaccines. The $135,747.00 contract has an August 25, 2020 completion date. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit manufacturer that has provided a range of pharmaceutical products, including vaccines, antiviral medications, and respiratory treatments, to federal customers such as the Department of...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm-fixed price delivery order to Teva Pharmaceuticals USA, Inc. for the supply of Adenovirus Type 4 vaccine. The $271,494.00 contract has an October 27, 2020 completion date and was awarded on October 19, 2020. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit manufacturer that provides a range of pharmaceutical products, including vaccines, antiviral medications, and respiratory treatments, to federal agencies...
- Teva Pharmaceuticals USA, Inc. has been awarded a $305,393.76 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to provide adenovirus type 4 vaccine. Performance will take place in Parsippany, New Jersey through December 2023. This delivery order was issued against an existing contract vehicle and supports the immunization programs of the military. Teva Pharmaceuticals has a history of partnering with subcontractors and receiving contract awards to supply...
- The Defense Logistics Agency Troop Support Medical awarded a firm-fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned for-profit pharmaceutical manufacturer, to provide Adenovirus Type 4 vaccine. The $135,747 order has an October 27, 2020 completion date and was awarded on October 19, 2020. Teva Pharmaceuticals USA, Inc. has provided various drug products, including vaccines, to federal agencies such as the Department of Defense and Department of Veterans Affairs. While...
- Teva Pharmaceuticals USA, Inc. has been awarded a $458,090.64 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply adenovirus type 4 vaccine. The delivery order was awarded on December 14, 2023 and has a completion date of December 19, 2023. Teva Pharmaceuticals USA, Inc. will deliver the adenovirus type 4 vaccine to support immunization programs of the military, as the Defense Logistics Agency Troop Support Medical maintains stockpiles and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccine. The contract has a firm fixed price of $282,353.76 and a completion date of February 23, 2021. The place of performance is Parsippany, New Jersey. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit organization that manufactures a range of drug products, including vaccines,...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $476,414.19 firm fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, to provide Adenovirus Type 4 vaccines. This contract, which has a completion date of May 21, 2024, supports military immunization programs. Teva Pharmaceuticals USA, Inc. has a long history of supplying critical pharmaceuticals, including other vaccines and medications, to various federal...